Web-based Tailored Information and Support for Patients With a Neuroendocrine Tumor (WIN-study).
18 Years
N/A
Both
Distress, Quality of Life, Neuroendocrine Tumor
Trial Information
Web-based Tailored Information and Support for Patients With a Neuroendocrine Tumor (WIN-study).
Inclusion Criteria:
- Adult NET patients (aged ≥ 18 years of age) with any tumor site and disease stage.
- Ability to comprehend Dutch (both reading and writing).
- Informed consent provided.
Exclusion Criteria:
- Estimated life expectancy less than 3 months.
- Patients with a second primary tumor for which active follow-up or treatment.
Type of Study:
Interventional
Study Design:
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention
Outcome Measure:
detect an improvement in perception and satisfaction of the received information
Outcome Description:
The primary objective is to detect an improvement in perception and satisfaction of the received information by NET-patients after having used the online tailored information and support system. We hypothesize that patients perceive to have received more information and are more satisfied with the received information after having used the web-based tailored information and support system.
Outcome Time Frame:
14 weeks. This is the period a patient can use the website, thereafter a end-of study questionnaire will be filled out
Safety Issue:
No
Principal Investigator
A.M.E. Walenkamp, MD, PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
University Medical Centre Groningen
Authority:
Netherlands: Medical Ethics Review Committee (METC)
Study ID:
WIN-2013
NCT ID:
NCT01849523
Start Date:
May 2013
Completion Date:
September 2014
Related Keywords:
- Distress
- Quality of Life
- Neuroendocrine Tumor
- Neuroendocrine tumor
- Website
- Information
- Psychosocial support
- Neuroendocrine Tumors
Name | Location |
|---|
